World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
59
Citations
12161
World Ranking
3430
National Ranking
1593

George Kemble publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where George Kemble sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 118 publications — 6th percentile

6% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

George Kemble D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where George Kemble sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 59 D-Index — 32nd percentile

32% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

George Kemble is affiliated with Sagimet Biosciences in the United States and has an active research profile focused on medicine and biochemistry, genetics, and molecular biology. Their work spans several specialized subfields including cancer research, pulmonary and respiratory medicine, molecular biology, epidemiology, and hepatology.

The main topics of their research encompass the intersection of cancer, lipids, and metabolism, liver disease diagnosis and treatment, cancer under hypoxic conditions, ferroptosis and cancer prognosis, RNA modifications related to cancer, lung cancer treatments and mutations, as well as diet and metabolism studies.

Kemble's recent papers include:

  • "Denifanstat for the treatment of metabolic dysfunction-associated steatohepatitis: a multicentre, double-blind, randomised, placebo-controlled, phase 2b trial," 2024, The 'Lancet. Gastroenterology & hepatology
  • "Fatty acid synthase (FASN) inhibition cooperates with BH3 mimetic drugs to overcome resistance to mitochondrial apoptosis in pancreatic cancer," 2025, Neoplasia
  • "Author Correction: Targeting de novo lipogenesis and the Lands cycle induces ferroptosis in KRAS-mutant lung cancer," 2022, Nature Communications
  • "Multicenter, randomized, double-blind, placebo-controlled trial of Fatty Acid Synthase (FASN) inhibitor, denifanstat, versus placebo in the treatment of biopsy-proven NASH: A 26-week interim analysis of the FASCINATE-2 Phase 2B trial," 2023, Journal of Hepatology
  • "Targeting de novo lipogenesis and the Lands cycle induces ferroptosis in KRAS-mutant lung cancer," 2021, bioRxiv (Cold Spring Harbor Laboratory)

The scientist often collaborates with several frequent co-authors, including Rohit Loomba, Katharine Grimmer, Eduardo B. Martins, Marie O'Farrell, and Wen-Wei Tsai. Kemble's work has been published mainly in the Journal of Hepatology, with additional publications in The 'Lancet. Gastroenterology & hepatology, Neoplasia, Nature Communications, and bioRxiv (Cold Spring Harbor Laboratory).

The focus on therapeutic interventions and molecular mechanisms is evident through the research on fatty acid synthase inhibition, metabolic dysfunction-associated steatohepatitis, ferroptosis in KRAS-mutant lung cancer, and mitochondrial apoptosis in pancreatic cancer. The use of clinical trial data further highlights Kemble's involvement in translational biomedical research.

Best Publications

  • Live attenuated versus inactivated influenza vaccine in infants and young children.

    Robert B. Belshe;Kathryn M. Edwards;Timo Vesikari;Steven V. Black

  • Human cytomegalovirus clinical isolates carry at least 19 genes not found in laboratory strains.

    Tai-An Cha;E. Tom;G. W. Kemble;G. M. Duke

  • Cytomegalovirus encodes a potent alpha chemokine.

    Mark E. T. Penfold;Daniel J. Dairaghi;Gregory M. Duke;Noah Saederup

  • Multiple amino acid residues confer temperature sensitivity to human influenza virus vaccine strains (flumist) derived from cold-adapted a/ann arbor/6/60

    Hong Jin;Bin Lu;Helen Zhou;Chienhui Ma

  • Cellular immune responses in children and adults receiving inactivated or live attenuated influenza vaccines.

    Xiao-Song He;Tyson H. Holmes;Caiqiu Zhang;Kutubuddin Mahmood

  • Glycosylation at 158N of the Hemagglutinin Protein and Receptor Binding Specificity Synergistically Affect the Antigenicity and Immunogenicity of a Live Attenuated H5N1 A/Vietnam/1203/2004 Vaccine Virus in Ferrets

    Weijia Wang;Bin Lu;Helen Zhou;Amorsolo L. Suguitan

  • Live, Attenuated Influenza A H5N1 Candidate Vaccines Provide Broad Cross-Protection in Mice and Ferrets

    Amorsolo L Suguitan;Josephine McAuliffe;Kimberly L Mills;Hong Jin

  • Influence of Prior Influenza Vaccination on Antibody and B-Cell Responses

    Sanae Sasaki;Xiao-Song He;Xiao-Song He;Tyson H. Holmes;Cornelia L. Dekker

  • Rescue of influenza B virus from eight plasmids

    Erich Hoffmann;Kutubuddin Mahmood;Chin-Fen Yang;Robert G. Webster

  • A deletion mutant in the human cytomegalovirus gene encoding IE1(491aa) is replication defective due to a failure in autoregulation.

    Edward S. Mocarski;George W. Kemble;John M. Lyle;Richard F. Greaves

  • Comparison of the Influenza Virus-Specific Effector and Memory B-Cell Responses to Immunization of Children and Adults with Live Attenuated or Inactivated Influenza Virus Vaccines

    Sanae Sasaki;Maria C. Jaimes;Maria C. Jaimes;Tyson H. Holmes;Cornelia L. Dekker

  • Cytomegalovirus UL97 Phosphotransferase Mutations That Affect Susceptibility to Ganciclovir

    Sunwen Chou;Sunwen Chou;Rachel H. Waldemer;Rachel H. Waldemer;Anne E. Senters;Anne E. Senters;Kevin S. Michels;Kevin S. Michels

  • Persistent and Selective Deficiency of CD4+ T Cell Immunity to Cytomegalovirus in Immunocompetent Young Children

    Wenwei Tu;Sharon Chen;Margaret Sharp;Corry Dekker

  • A review of genetic differences between limited and extensively passaged human cytomegalovirus strains.

    M. N. Prichard;M. E. T. Penfold;G. M. Duke;R. R. Spaete

  • Generation of Live Attenuated Novel Influenza Virus A/California/7/09 (H1N1) Vaccines with High Yield in Embryonated Chicken Eggs

    Zhongying Chen;Weijia Wang;Helen Zhou;Amorsolo L. Suguitan

  • T cell–dependent production of IFN-γ by NK cells in response to influenza A virus

    Xiao Song He;Monia Draghi;Kutubuddin Mahmood;Tyson H. Holmes

  • Fatty acid synthase - Modern tumor cell biology insights into a classical oncology target.

    Douglas Buckley;Gregory Duke;Timothy S. Heuer;Marie O'Farrell

  • Improvement of Influenza A/Fujian/411/02 (H3N2) Virus Growth in Embryonated Chicken Eggs by Balancing the Hemagglutinin and Neuraminidase Activities, Using Reverse Genetics

    Bin Lu;Helen Zhou;Dan Ye;George Kemble

  • Evaluation of two live attenuated cold-adapted H5N1 influenza virus vaccines in healthy adults.

    Ruth A. Karron;Kawsar Talaat;Catherine Luke;Karen Callahan

  • Two residues in the hemagglutinin of A/Fujian/411/02-like influenza viruses are responsible for antigenic drift from A/Panama/2007/99.

    Hong Jin;Helen Zhou;Hui Liu;Winnie Chan

  • Defined large-scale alterations of the human cytomegalovirus genome constructed by cotransfection of overlapping cosmids.

    G Kemble;G Duke;R Winter;R Spaete

Frequent Co-Authors

Hong Jin
Hong Jin AstraZeneca (United Kingdom)
Harry B. Greenberg
Harry B. Greenberg Stanford University
Kanta Subbarao
Kanta Subbarao University of Melbourne
Ann M. Arvin
Ann M. Arvin Stanford University
Xiao-Song He
Xiao-Song He University of California, Davis
Cornelia L. Dekker
Cornelia L. Dekker Stanford University
Brian R. Murphy
Brian R. Murphy National Institute of Allergy and Infectious Diseases
David E. Swayne
David E. Swayne United States Department of Agriculture
Edward S. Mocarski
Edward S. Mocarski Emory University
Ruth A. Karron
Ruth A. Karron Johns Hopkins University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in combining Immunology with healthcare, pursuing a degree as a Nurse Practitioner (NP) can be a rewarding pathway. Those looking for programs with more accessible entry points might explore nurse practitioner programs with easy admission, which can help streamline the enrollment process.

Specializing further, many choose to become Psychiatric Mental Health Nurse Practitioners (PMHNPs), a field that benefits greatly from immunology knowledge due to the growing understanding of the immune system’s role in mental health. To secure quality clinical experiences, researching top online pmhnp programs is essential for connecting academic theories with hands-on practice.

Budget-conscious students may want to consider cheapest psychiatric nurse practitioner programs, which offer affordable pathways without compromising educational quality. This can make advanced degrees more attainable while still preparing students for vital healthcare roles.

Graduates pursuing a Doctor of Nursing Practice (DNP) degree can expect competitive salaries that vary by location. To understand potential earnings, it’s helpful to review data on how much a dnp makes, which highlights salary trends and can guide career decisions based on financial goals.

Best Scientists Citing George Kemble

Trending Scientists

Recently Published Articles